Vanguard Group’s Dianthus Therapeutics DNTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$26.9M Buy
1,446,081
+337,206
+30% +$6.28M ﹤0.01% 2415
2025
Q1
$20.1M Sell
1,108,875
-165,763
-13% -$3.01M ﹤0.01% 2497
2024
Q4
$27.8M Sell
1,274,638
-20,331
-2% -$443K ﹤0.01% 2424
2024
Q3
$35.5M Buy
1,294,969
+49,741
+4% +$1.36M ﹤0.01% 2323
2024
Q2
$32.2M Buy
1,245,228
+707,400
+132% +$18.3M ﹤0.01% 2332
2024
Q1
$16.1M Buy
537,828
+384,182
+250% +$11.5M ﹤0.01% 2705
2023
Q4
$1.6M Buy
153,646
+26,769
+21% +$278K ﹤0.01% 3678
2023
Q3
$1.73M Buy
126,877
+3,851
+3% +$52.6K ﹤0.01% 3638
2023
Q2
$1.49M Hold
123,026
﹤0.01% 3764
2023
Q1
$1.56M Buy
123,026
+261
+0.2% +$3.32K ﹤0.01% 3767
2022
Q4
$776K Buy
122,765
+50
+0% +$316 ﹤0.01% 3989
2022
Q3
$2.77M Buy
122,715
+3,479
+3% +$78.5K ﹤0.01% 3612
2022
Q2
$2.29M Buy
119,236
+3,003
+3% +$57.7K ﹤0.01% 3749
2022
Q1
$5.39M Sell
116,233
-4,595
-4% -$213K ﹤0.01% 3491
2021
Q4
$8.56M Sell
120,828
-9,903
-8% -$702K ﹤0.01% 3308
2021
Q3
$15.2M Buy
130,731
+34,244
+35% +$3.99M ﹤0.01% 3007
2021
Q2
$15.1M Buy
96,487
+7,520
+8% +$1.18M ﹤0.01% 2992
2021
Q1
$16.9M Buy
88,967
+6,374
+8% +$1.21M ﹤0.01% 2871
2020
Q4
$10.4M Buy
82,593
+8,467
+11% +$1.06M ﹤0.01% 2972
2020
Q3
$8.07M Buy
74,126
+754
+1% +$82K ﹤0.01% 2889
2020
Q2
$8.82M Buy
73,372
+17,608
+32% +$2.12M ﹤0.01% 2839
2020
Q1
$5.6M Buy
55,764
+684
+1% +$68.7K ﹤0.01% 2926
2019
Q4
$13.4M Sell
55,080
-156
-0.3% -$37.8K ﹤0.01% 2720
2019
Q3
$9.07M Sell
55,236
-36
-0.1% -$5.91K ﹤0.01% 2864
2019
Q2
$13M Buy
55,272
+23,759
+75% +$5.61M ﹤0.01% 2709
2019
Q1
$8.31M Buy
31,513
+22,854
+264% +$6.02M ﹤0.01% 2920
2018
Q4
$790K Sell
8,659
-370
-4% -$33.8K ﹤0.01% 3633
2018
Q3
$1.74M Buy
9,029
+4,341
+93% +$834K ﹤0.01% 3577
2018
Q2
$1.01M Buy
+4,688
New +$1.01M ﹤0.01% 3685